Gabriele Bergers, PhD

Title(s)Professor, Neurological Surgery
SchoolSchool of Medicine
AddressLocation Required
Varies CA 00000
Phone415-476-6786
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Research 
    Collapse Research Activities and Funding
    Inter-regulatory function of immune-modulation and angiogenesis in cancer
    NIH R01CA201537Aug 1, 2016 - Jul 31, 2021
    Role: Principal Investigator
    Autophagy as a microenvironmental regulator of tumorigenesis and resistance
    NIH R01CA188404Sep 1, 2014 - Aug 31, 2020
    Role: Co-Principal Investigator
    Biophysical and molecular dialogue of glioma cells and the brain microenvironment
    NIH U54CA163155Sep 26, 2011 - Jul 31, 2016
    Role: Principal Investigator
    Multipotential mesenchymal stem cell-like cells in pancreatic tumorigenesis
    NIH R01CA154383Apr 1, 2011 - Mar 31, 2016
    Role: Principal Investigator
    Perivascular Invasion of GBMs
    NIH R01CA113382Aug 15, 2006 - May 31, 2011
    Role: Principal Investigator
    PDGFRbeta+-Perivascular Cells In Tumor Angiogenesis
    NIH R01CA109390Aug 1, 2004 - Jul 31, 2009
    Role: Principal Investigator
    Mechanism and therapeutic targeting of evasive resistance to antiangiogenic drugs
    NIH R01CA099948Feb 11, 2003 - May 31, 2013
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer. Front Immunol. 2021; 12:736670. Vella G, Guelfi S, Bergers G. PMID: 34484246.
      View in: PubMed   Mentions:    Fields:    
    2. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021 03; 21(3):162-180. Bergers G, Fendt SM. PMID: 33462499.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    3. Tumors vs. Chronic Wounds: An Immune Cell's Perspective. Front Immunol. 2019; 10:2178. Hua Y, Bergers G. PMID: 31572387.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    4. Peptide-guided nanoparticles for glioblastoma targeting. J Control Release. 2019 08 28; 308:109-118. Säälik P, Lingasamy P, Toome K, Mastandrea I, Rousso-Noori L, Tobi A, Simón-Gracia L, Hunt H, Paiste P, Kotamraju VR, Bergers G, Asser T, Rätsep T, Ruoslahti E, Bjerkvig R, Friedmann-Morvinski D, Teesalu T. PMID: 31255690.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    5. TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA. Neuro-Oncology. 2019 Apr 23; 21(Supplement_2):ii121-ii122. Wang WW, Grossauer GS, Koeck KK, Simonds SE, Lu LE, Bergers BG, Weiss WW, Petritsch PC. .
      View in: Publisher Site   Mentions:
    6. Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis. Annu Rev Physiol. 2019 02 10; 81:535-560. Mazzone M, Bergers G. PMID: 30742781.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    7. Where Have All the T Cells Gone? Immunity. 2018 10 16; 49(4):592-594. Vella G, Bergers G. PMID: 30332627.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    8. A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nat Cell Biol. 2018 10; 20(10):1203-1214. Barnes JM, Kaushik S, Bainer RO, Sa JK, Woods EC, Kai F, Przybyla L, Lee M, Lee HW, Tung JC, Maller O, Barrett AS, Lu KV, Lakins JN, Hansen KC, Obernier K, Alvarez-Buylla A, Bergers G, Phillips JJ, Nam DH, Bertozzi CR, Weaver VM. PMID: 30202050.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    9. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018 08; 21(3):425-532. Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW. PMID: 29766399.
      View in: PubMed   Mentions: 140     Fields:    Translation:HumansAnimals
    10. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer. Semin Cancer Biol. 2018 10; 52(Pt 2):107-116. Missiaen R, Mazzone M, Bergers G. PMID: 29935312.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    11. Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. J Pathol. 2018 06; 245(2):209-221. He B, Jabouille A, Steri V, Johansson-Percival A, Michael IP, Kotamraju VR, Junckerstorff R, Nowak AK, Hamzah J, Lee G, Bergers G, Ganss R. PMID: 29603739.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    12. ANGI-12. IDENTIFICATION OF A NOVEL TYROSINE KINASE/INTEGRIN COMPLEX THAT DRIVES BRAIN METASTASES. Neuro-Oncology. 2017 Nov 6; 19(suppl_6):vi24-vi24. Jahangiri JA, Sidorov SM, Nguyen NA, Yagnik YG, Han HS, Mascharak MS, De Lay DM, Wagner WJ, Castro CB, Imber IB, Lu LK, Bergers BG, Weiss WW, Aghi AM. .
      View in: Publisher Site   Mentions:
    13. Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors. Oncotarget. 2017 Nov 21; 8(59):99207-99208. Allen E, Missiaen R, Bergers G. PMID: 29245888.
      View in: PubMed   Mentions: 1     Fields:    
    14. Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer. Proc Natl Acad Sci U S A. 2017 10 10; 114(41):E8685-E8694. Jahangiri A, Nguyen A, Chandra A, Sidorov MK, Yagnik G, Rick J, Han SW, Chen W, Flanigan PM, Schneidman-Duhovny D, Mascharak S, De Lay M, Imber B, Park CC, Matsumoto K, Lu K, Bergers G, Sali A, Weiss WA, Aghi MK. PMID: 28973887.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    15. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017 04 12; 9(385). Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G. PMID: 28404866.
      View in: PubMed   Mentions: 157     Fields:    Translation:AnimalsCells
    16. Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations. Cold Spring Harb Symp Quant Biol. 2016; 81:21-29. Allen E, Missiaen R, Bergers G. PMID: 28396525.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    17. DRES-11. A CROSS-ACTIVATING c-Met/ß1 INTEGRIN COMPLEX DRIVES THERAPEUTIC RESISTANCE IN GLIOBLASTOMA. Neuro-Oncology. 2016 Nov 1; 18(suppl_6):vi53-vi54. Jahangiri JA, Sidorov SM, Han HS, Chen CW, Rick RJ, Schneidman-Duhovny SD, Mascharak MS, De Lay DM, Wagner WJ, Castro CB, Imber IB, Flanigan FP, Kuang KR, Lu LK, Bergers BG, Sali SA, Weiss WW, Aghi AM. .
      View in: Publisher Site   Mentions:
    18. Glioblastoma: Defining Tumor Niches. Trends Cancer. 2015 Dec; 1(4):252-265. Hambardzumyan D, Bergers G. PMID: 27088132.
      View in: PubMed   Mentions: 116     Fields:    
    19. CBIO-05UNDERSTANDING AND TACKLING PARACRINE SIGNALING CUES BETWEEN GLIOMA AND IMMUNE CELLS TO THWART GLIOMA INVASIVENESS AND ANGIOGENESIS. Neuro-Oncology. 2015 Nov 1; 17(suppl_5):v55-v56. Lu LK, Hambardzumyan HD, Bergers BG. .
      View in: Publisher Site   Mentions:
    20. CANCER. Tumor angiogenesis, from foe to friend. Science. 2015 Aug 14; 349(6249):694-5. Rivera LB, Bergers G. PMID: 26273044.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    21. Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy. Cell Rep. 2015 Apr 28; 11(4):577-91. Rivera LB, Meyronet D, Hervieu V, Frederick MJ, Bergsland E, Bergers G. PMID: 25892230.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimalsCells
    22. Intertwined regulation of angiogenesis and immunity by myeloid cells. Trends Immunol. 2015 Apr; 36(4):240-9. Rivera LB, Bergers G. PMID: 25770923.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    23. HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer. NMR Biomed. 2014 Nov; 27(11):1361-70. Wang AS, Lodi A, Rivera LB, Izquierdo-Garcia JL, Firpo MA, Mulvihill SJ, Tempero MA, Bergers G, Ronen SM. PMID: 25199993.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    24. UNDERSTANDING AND TACKLING THE TUMOR-IMMUNE CELL DIALOGUE DURING PROGRESSION AND THERAPEUTIC RESISTANCE. Neuro-Oncology. 2014 Jul 1; 16(suppl_3):iii16-iii16. Bergers BG, Lu LK, Rivera RL. .
      View in: Publisher Site   Mentions:
    25. HIGH INTERSTITIAL FLUID PRESSURE REGULATES TUMOR GROWTH AND DRUG UPTAKE IN HUMAN GLIOBLASTOMA. Neuro-Oncology. 2014 Jul 1; 16(suppl_3):iii32-iii32. Persson PA, Ilkhanizadeh IS, Miroshnikova MY, Frantz FA, Lakins LJ, James JC, McKnight MT, Berger BM, Bergers BG, Weiss WW, Weaver WV. .
      View in: Publisher Site   Mentions:
    26. Angiogenesis. Targeting vascular sprouts. Science. 2014 Jun 27; 344(6191):1449-50. Rivera LB, Bergers G. PMID: 24970064.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    27. Novel target for peptide-based imaging and treatment of brain tumors. . 2014 Apr; 13(4):996-1007. Hyvönen M, Enbäck J, Huhtala T, Lammi J, Sihto H, Weisell J, Joensuu H, Rosenthal-Aizman K, El-Andaloussi S, Langel U, Närvänen A, Bergers G, Laakkonen P. PMID: 24493698.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    28. Escape mechanisms from antiangiogenic therapy: an immune cell's perspective. Adv Exp Med Biol. 2014; 772:83-99. Rivera L, Pandika M, Bergers G. PMID: 24272355.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    29. Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity. Cancer Cell. 2013 Dec 09; 24(6):687-9. Rivera LB, Bergers G. PMID: 24332035.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    30. Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance. Clin Cancer Res. 2013 Apr 01; 19(7):1773-83. Jahangiri A, De Lay M, Miller LM, Carbonell WS, Hu YL, Lu K, Tom MW, Paquette J, Tokuyasu TA, Tsao S, Marshall R, Perry A, Bjorgan KM, Chaumeil MM, Ronen SM, Bergers G, Aghi MK. PMID: 23307858.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansAnimalsCells
    31. Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma. CNS Oncol. 2013 Jan; 2(1):49-65. Lu KV, Bergers G. PMID: 23750318.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    32. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 2012 Jul 10; 22(1):21-35. Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G. PMID: 22789536.
      View in: PubMed   Mentions: 252     Fields:    Translation:HumansCells
    33. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 2011 Sep 13; 20(3):328-40. Sugiarto S, Persson AI, Munoz EG, Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J, Phillips J, Siu J, Lim DA, Vandenberg S, Stallcup W, Berger MS, Bergers G, Weiss WA, Petritsch C. PMID: 21907924.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansAnimalsCells
    34. Tumor microenvironment and progression. J Surg Oncol. 2011 May 01; 103(6):468-74. Dvorak HF, Weaver VM, Tlsty TD, Bergers G. PMID: 21480238.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    35. Non-stem cell origin for oligodendroglioma. Cancer Cell. 2010 Dec 14; 18(6):669-82. Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, McKnight TR, Goldman SA, Weiss WA. PMID: 21156288.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansAnimalsCells
    36. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res. 2009 Sep 01; 69(17):6889-98. Lu KV, Zhu S, Cvrljevic A, Huang TT, Sarkaria S, Ahkavan D, Dang J, Dinca EB, Plaisier SB, Oderberg I, Lee Y, Chen Z, Caldwell JS, Xie Y, Loo JA, Seligson D, Chakravari A, Lee FY, Weinmann R, Cloughesy TF, Nelson SF, Bergers G, Graeber T, Furnari FB, James CD, Cavenee WK, Johns TG, Mischel PS. PMID: 19690143.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansAnimalsCells
    37. Identifying Mechanisms of Bevacizumab Evasion in Human Glioblastoma. Neurosurgery. 2009 Aug 1; 65(2):424. Aghi AM, Rose RS, VandenBerg VS, Bergers BG. .
      View in: Publisher Site   Mentions:
    38. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009 Mar 03; 15(3):220-31. Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, Inoue M, Bergers G, Hanahan D, Casanovas O. PMID: 19249680.
      View in: PubMed   Mentions: 976     Fields:    Translation:HumansAnimals
    39. Bone Marrow-Derived Cells in GBM Neovascularization. CNS Cancer. 2009 Jan 1; 749-773. Bergers BG. .
      View in: Publisher Site   Mentions:
    40. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008 Aug; 8(8):592-603. Bergers G, Hanahan D. PMID: 18650835.
      View in: PubMed   Mentions: 1146     Fields:    Translation:HumansCells
    41. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008 Jun 24; 6:14. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. PMID: 18577219.
      View in: PubMed   Mentions: 430     Fields:    Translation:HumansAnimalsCells
    42. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol. 2008 Jun; 10(3):254-64. Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G. PMID: 18359864.
      View in: PubMed   Mentions: 50     Fields:    Translation:Animals
    43. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008 Mar; 13(3):206-20. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. PMID: 18328425.
      View in: PubMed   Mentions: 496     Fields:    Translation:AnimalsCells
    44. HIFa induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis. The FASEB Journal. 2008 Mar 1; 22:88.2-88.2. Bergers BG. .
      View in: Publisher Site   Mentions:
    45. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med. 2008 Jan 29; 5(1):e19. Pietras K, Pahler J, Bergers G, Hanahan D. PMID: 18232728.
      View in: PubMed   Mentions: 164     Fields:    Translation:HumansAnimalsCells
    46. Chapter 3. Bone marrow-derived vascular progenitors and proangiogenic monocytes in tumors. Methods Enzymol. 2008; 445:53-82. Lu K, Lamagna C, Bergers G. PMID: 19022055.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    47. Pericytes, the Mural Cells of the Microvascular System. Angiogenesis. 2008 Jan 1; 45-53. Bergers BG. .
      View in: Publisher Site   Mentions:
    48. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Res. 2007 Oct 01; 67(19):9435-42. Chesler L, Goldenberg DD, Seales IT, Satchi-Fainaro R, Grimmer M, Collins R, Struett C, Nguyen KN, Kim G, Tihan T, Bao Y, Brekken RA, Bergers G, Folkman J, Weiss WA. PMID: 17909053.
      View in: PubMed   Mentions: 24     Fields:    Translation:Animals
    49. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Cancer Res. 2006 Dec 01; 66(23):11331-40. Kawaguchi T, Yamashita Y, Kanamori M, Endersby R, Bankiewicz KS, Baker SJ, Bergers G, Pieper RO. PMID: 17145879.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    50. ID: 373 MMP-9-dependent regulation of angiogenesis and invasion in GBM. Journal of Thrombosis and Haemostasis. 2006 Oct 1; 4(s1):46-46. Du DR, Petritsch PC, Song SH, Werb WZ, Bergers BG. .
      View in: Publisher Site   Mentions:
    51. The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol. 2006 Oct; 80(4):677-81. Lamagna C, Bergers G. PMID: 16888086.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCells
    52. Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents. Cancer Metastasis Rev. 2006 Jun; 25(2):243-52. Holash J, Thurston G, Rudge JS, Yancopoulos GD, Adjei AA, Bergers G, Pytowski B, Pegram M, Gordon MS. PMID: 16770536.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    53. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005 Oct; 8(4):299-309. Casanovas O, Hicklin DJ, Bergers G, Hanahan D. PMID: 16226705.
      View in: PubMed   Mentions: 590     Fields:    Translation:HumansCells
    54. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005 Oct; 7(4):452-64. Bergers G, Song S. PMID: 16212810.
      View in: PubMed   Mentions: 484     Fields:    Translation:HumansAnimalsCells
    55. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol. 2005 Sep; 7(9):870-9. Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G. PMID: 16113679.
      View in: PubMed   Mentions: 202     Fields:    Translation:AnimalsCells
    56. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood. 2005 Feb 01; 105(3):1094-101. Berger M, Bergers G, Arnold B, Hämmerling GJ, Ganss R. PMID: 15459006.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCells
    57. Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme. Cancer Res. 2004 Apr 15; 64(8):2751-8. Kanamori M, Vanden Berg SR, Bergers G, Berger MS, Pieper RO. PMID: 15087390.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    58. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. 2003 Nov; 4(5):393-403. Joyce JA, Laakkonen P, Bernasconi M, Bergers G, Ruoslahti E, Hanahan D. PMID: 14667506.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    59. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 2003 Aug; 4(2):133-46. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP, Johnson RS, Bergers G. PMID: 12957288.
      View in: PubMed   Mentions: 146     Fields:    Translation:AnimalsCells
    60. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003 Jun; 3(6):401-10. Bergers G, Benjamin LE. PMID: 12778130.
      View in: PubMed   Mentions: 1003     Fields:    Translation:HumansAnimals
    61. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003 May; 111(9):1287-95. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. PMID: 12727920.
      View in: PubMed   Mentions: 416     Fields:    Translation:AnimalsCells
    62. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res. 2002 May 15; 62(10):2731-5. Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS. PMID: 12019144.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    63. Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice. Cold Spring Harb Symp Quant Biol. 2002; 67:293-300. Bergers G, Hanahan D. PMID: 12858552.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    64. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000 Oct; 2(10):737-44. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. PMID: 11025665.
      View in: PubMed   Mentions: 829     Fields:    Translation:AnimalsCells
    65. Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects. Expert Opinion on Therapeutic Targets. 2000 Oct 1; 4(5):609-633. Sternlicht SM, Bergers BG. .
      View in: Publisher Site   Mentions:
    66. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest. 2000 Apr; 105(8):1045-7. Hanahan D, Bergers G, Bergsland E. PMID: 10772648.
      View in: PubMed   Mentions: 189     Fields:    Translation:HumansAnimalsCells
    67. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev. 2000 Feb; 10(1):120-7. Bergers G, Coussens LM. PMID: 10679388.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimals
    68. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999 Jun 01; 13(11):1382-97. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D. PMID: 10364156.
      View in: PubMed   Mentions: 278     Fields:    Translation:HumansAnimalsCells
    69. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 1999 Apr 30; 284(5415):808-12. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. PMID: 10221914.
      View in: PubMed   Mentions: 215     Fields:    Translation:Animals
    70. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998 May 01; 93(3):411-22. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. PMID: 9590175.
      View in: PubMed   Mentions: 451     Fields:    Translation:AnimalsCells
    71. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol. 1998; 42(7):995-1002. Bergers G, Hanahan D, Coussens LM. PMID: 9853830.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    72. Life events, emotional eating and change in body mass index. Int J Obes. 1986; 10(1):29-35. Van Strien T, Rookus MA, Bergers GP, Frijters JE, Defares PB. PMID: 3710686.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    Gabriele's Networks
    Concepts (326)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (31)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-866-g4098221c on PROFILES-PWEB01.

    Copyright © The Regents of the University of California